Adicet Bio Inc (ACET) USD0.0001
Sell:$1.91Buy:$1.92
$0.11 (5.43%)
- This stock can be held in a
Stocks and Shares ISASell:$1.91
Buy:$1.92
Change:$0.11 (5.43%)
$0.11 (5.43%)Prices delayed by at least 15 minutes
Sell:$1.91
Buy:$1.92
Change:$0.11 (5.43%)
$0.11 (5.43%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 25 January 2024 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 1,841,100 | $2.40 | $4,418,640.00 | 7,526,359 |
| 25 January 2024 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 1,041,700 | $2.40 | $2,500,080.00 | 1,255,985 |
| 25 January 2024 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 242,200 | $2.40 | $581,280.00 | 990,254 |
| 24 January 2024 | Chen SchorPresident/CEO | Sell Tax related | 15,290 | $2.40 | $36,696.00 | 138,471 |
| 24 January 2024 | Francesco GalimiChief Level Officer | Sell Tax related | 4,957 | $2.40 | $11,896.80 | 75,501 |
| 24 January 2024 | Brian Nicholas HarveyCFO | Sell Tax related | 4,320 | $2.40 | $10,368.00 | 73,500 |
| 24 January 2024 | Donald G HealeyCTO | Sell Tax related | 4,870 | $2.40 | $11,688.00 | 52,629 |
| 24 January 2024 | Blake T AftabChief Level Officer | Sell Tax related | 3,565 | $2.40 | $8,556.00 | 42,811 |
| 12 October 2023 | Blake T AftabChief Level Officer | Sell Tax related | 7,933 | $1.35 | $10,709.55 | 46,376 |
| 2 October 2023 | Chen SchorPresident/CEO | Sell Tax related | 23,208 | $1.37 | $31,794.96 | 153,761 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 25 January 2024 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 1,841,100 | $2.40 | $4,418,640.00 | 7,526,359 |
| 25 January 2024 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 1,041,700 | $2.40 | $2,500,080.00 | 1,255,985 |
| 27 June 2023 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 442,000 | $2.09 | $923,780.00 | 5,685,259 |
| 25 January 2024 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 242,200 | $2.40 | $581,280.00 | 990,254 |
| 27 June 2023 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 250,000 | $2.09 | $522,500.00 | 646,657 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.